phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Coronary Restenosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun-Dullaeus, RC; Brunsch, H; Daniel, JM; Hersemeyer, K; Kanse, SM; Kemkes-Matthes, B; Muhl, L; Preissner, KT; Sedding, D; Tillmanns, H; Weimer, T | 1 |
1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Coronary Restenosis
| Article | Year |
|---|---|
The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation.
Topics: Actins; Amino Acid Chloromethyl Ketones; Animals; Becaplermin; Catalysis; Cell Proliferation; Coronary Restenosis; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Heparin; Humans; Intercellular Signaling Peptides and Proteins; Liver; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Phosphorylation; Platelet-Derived Growth Factor; Polymorphism, Genetic; Protein Binding; Proto-Oncogene Proteins c-sis; Serine Endopeptidases; Serine Proteinase Inhibitors; Tunica Intima; Urokinase-Type Plasminogen Activator; von Willebrand Factor | 2006 |